RNA therapeutics can silence oncogenic transcripts, modulate RNA processing, restore protein expression, or encode tumor antigens. Their development, however, is constrained by target selection, molecular design, delivery, immunogenicity, and inter-patient heterogeneity. Artificial intelligence (AI) is increasingly app...
William S. O. Symmans, Zi-Yi Li, G. Calin et al.· Cell Reports Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.